EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exosomes in Hypertrophic Scars and Keloids: Mechanisms and Therapeutic Potentials—A Narrative Review

Mengke Wu, Jianfeng Zhang, Na Xiong, Yixiao Ma, Lingling Yong, Huaxu Liu, Qin Guo iD

Journal of Cosmetic Dermatology · 2026

DOI: 10.1111/jocd.70705 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Mengke Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China. Hauptthemen laut MEDLINE: Keloid, Cicatrix, Hypertrophic, Exosomes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation Project of Nanjing University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertrophic scars and keloids, types of pathological scars, arise from dysregulated wound healing, marked by abnormal fibroblast activation and excessive extracellular matrix (ECM) deposition. Current treatments have high recurrence rates and side effects, necessitating targeted therapies. Exosomes, extracellular vesicles mediating intercellular communication, offer multi‐target regulatory potential to address scar formation complexities.

Methods

This narrative review synthesizes in vitro and in vivo studies (2020–2025) from PubMed and Scopus on exosomes' role in regulating hypertrophic scars and keloids, proposing innovative therapeutic approaches.

Results

Therapeutic exosomes attenuate inflammation, promote wound healing, inhibit fibrosis, and modulate the scar microenvironment. They suppress fibroblast‐to‐myofibroblast transformation, regulate collagen synthesis, and inhibit fibrotic pathways, particularly via the Transforming Growth Factor‐beta/Sma‐ and Mad‐related protein (TGF‐β/Smad) signaling pathway.

Conclusion

Exosomes are a promising cell‐free therapy for pathological scars due to their multi‐target regulatory capabilities. Future research should optimize large‐scale production, standardize protocols, and develop targeted delivery systems to enable clinical translation, with validation through clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeloidCicatrix, HypertrophicExosomesHumansWound HealingSignal TransductionTransforming Growth Factor betaAnimalsFibroblastsFibrosisExtracellular Matrix

Stichwörter der Autor:innen

TGF‐β/Smadcell‐free therapyexosomefibrosishypertrophic scarkeloidwound healing

Substanzen

Transforming Growth Factor beta

Autor:innen und Institutionen

  • Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China.
  • Nanjing University of Chinese Medicine, Nanjing, China.
  • Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.

ORCID-Profile: Qin Guo

Förderung

  • Natural Science Foundation Project of Nanjing University of Chinese Medicine

Zitieren

APA

Wu, M., Zhang, J., Xiong, N., Ma, Y., Yong, L., Liu, H., & Guo, Q. (2026). Exosomes in Hypertrophic Scars and Keloids: Mechanisms and Therapeutic Potentials—A Narrative Review. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70705

Vancouver

Wu M, Zhang J, Xiong N, Ma Y, Yong L, Liu H, et al. Exosomes in Hypertrophic Scars and Keloids: Mechanisms and Therapeutic Potentials—A Narrative Review. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70705

BibTeX
@article{Wu2026,
  author = {Wu, Mengke and Zhang, Jianfeng and Xiong, Na and Ma, Yixiao and Yong, Lingling and Liu, Huaxu and Guo, Qin},
  title = {Exosomes in Hypertrophic Scars and Keloids: Mechanisms and Therapeutic Potentials—A Narrative Review},
  journal = {Journal of Cosmetic Dermatology},
  year = {2026},
  doi = {10.1111/jocd.70705}
}
Kostenlos starten →